Health authorities in Kent have confirmed that the number of meningitis cases linked to an outbreak in Canterbury has stabilised at 20, as a major vaccination campaign continues. The outbreak, which began in early March and is believed to be centred on Club Chemistry nightclub, has resulted in two deaths and several serious illnesses. Officials have distributed antibiotics to 30,000 people and plan to vaccinate up to 5,000 University of Kent students against meningitis B, the strain thought to be responsible.
Health Secretary Wes Streeting has urged calm, emphasising that the risk of transmission is low and advising students to continue attending university. However, demand for private vaccinations has surged, leading to temporary shortages at high street pharmacies such as Boots and Superdrug, which reported a spike in bookings. Experts describe the outbreak as the largest cluster of cases in a generation, likely caused by a super-spreading event.
Professor Andrew Preston, a microbial pathogenicity expert at the University of Bath, noted that the sudden severity of the illness in young people has heightened concern. Meningitis can cause rapid deterioration, with symptoms initially resembling a mild respiratory infection before escalating to life-threatening conditions. Nevertheless, Preston stressed that meningitis remains rare in the UK, with 378 cases recorded nationally between July 2024 and June 2025.
The UK has a successful vaccination programme for meningitis strains A, C, W and Y, with 88% of year 9 students vaccinated before the pandemic. These strains now account for less than 20% of cases. The current outbreak underscores the importance of continued vigilance and vaccination against meningitis B, which is not part of the routine adolescent immunisation schedule but is offered to at-risk groups.
